2021 OPIOID PRESCRIBING AND ABUSE WEBINAR SERIES
Buprenorphine in Opioid Use Disorder and Pain
Accredited for 1.0 AMA PRA Category 1 Credits™
Thursday, Oct. 14, 2021
Noon - 1:00 p.m. ET
Fee:
Members: Free
Nonmembers: $75
Registration required
Not a member? Join HERE.
Program description:
Buprenorphine is used in medication-assisted treatment of opioid use disorder. Due to its unique properties, its mechanism of action is often misunderstood. In this webinar, Dmitri M. Arbuck, MD, of the Indiana Polyclinic, will explain how buprenorphine works, how it is used and its benefits and pitfalls.
Objectives:
At the end of this webinar, attendees will be able to:
- Understand the main differences between the most frequently used opioids and buprenorphine.
- Explain the principles of buprenorphine prescribing.
- Develop insight into the basics of pharmacogenomics in relation to opioids.
- Explain ways to diminish perioperative opioid use.
Speaker:
Dmitry M. Arbuck, MD
President and Medical Director
Indiana Polyclinic, PC
About the speaker:
Dmitry M. Arbuck, MD, was born in Tbilisi, Republic of Georgia. He earned his medical degree at Yaroslavl State Medical School in Yaroslavl, Russia, where he also completed his internship in pediatrics and his residency in psychiatry. In the United States, he completed his psychiatry residency at Indiana University School of Medicine in Indianapolis.
Shortly after his training, Dr. Arbuck formed a pain management clinic that grew into the multidisciplinary facility know as Indiana Polyclinic (IPC). IPC specializes in treating the most difficult pain and psychiatric conditions that may have become resistant to treatment.
Dr. Arbuck has been certified by the American Board of Psychiatry and Neurology (2000), the National Board of Physicians and Surgeons (2016) and the former American Academy of Pain Management (2003). He practices psychiatry and pain medicine as dual specialties.
CME information
Designation Statement: The Indiana State Medical Association (ISMA) designates this live webinar for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement: The Indiana State Medical Association (ISMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Disclosure: In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by the ISMA must demonstrate balance, independence, objectivity and scientific rigor. Prior to the activity, all faculty, authors, editors and planning committee members participating in an ISMA-sponsored activity are required to disclose to attendees any relevant financial relationships with an “ineligible company” whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. None of the members of the CME Planning Committee or our speaker have any relevant financial relationships to disclose.
Note: While offering the CME credit hours listed in these pages, these activities are not intended to provide extensive training in a field.
Supported by an Educational Grant from:
If you have questions, contact ISMA Continuing Medical Education staff at 800-257-4762 or seminars@ismanet.org.
REGISTRATION DEADLINE: Oct. 14 @ 11 a.m. ET
REGISTRATION DETAILS - PLEASE NOTE:
Once registered, you will receive an immediate “Registration Confirmation” email containing dial in and web access information.